The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine
Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease
June 6, 2017 Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium This webinar provides a recommended framework for the selection and evaluation of wearable devices and their measurements for use
Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers
April 26, 2017-April 27, 2017 Eighth Annual Patient-Reported Outcome Consortium Workshop April 26 – 27, 2017 Hyatt Regency Bethesda, 1 Bethesda Metro Center, Bethesda, MD 20814 On April 26-27, 2017 the EIGHTH ANNUAL P
Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards: Extension to Biometric Monitoring Device (BMD) Assessments Arnerić, S.P., et al.; “Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards:
Two Arizona leaders in scientific collaboration partner to advance global TB research May 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTA